Denis Chem Lab shareholders approved the re-appointment of Dr. Himanshu C. Patel as Managing Director for a period of three years, effective August 1, 2026. This decision was part of the resolutions passed at the company's 45th Annual General Meeting (AGM), held on September 25, 2026.

The re-appointment was ratified via a Special Resolution, securing 99.31% votes in favor. Dr. Patel’s tenure extends to July 31, 2029. The disclosure confirms he is not debarred from holding office by SEBI or other authorities. His prior term expired on July 31, 2026, necessitating this renewal given his continued responsibilities in the pharmaceutical sector.

Key resolutions and voting results

Shareholders transacted several agenda items via e-voting, with results declared immediately following the meeting. The approved resolutions included the adoption of audited financial statements, declaration of dividend, director re-appointments, and auditor appointments. The specific voting outcomes are detailed below:

Governance and leadership updates

The re-appointment of Dr. Himanshu C. Patel was noted with his DIN: 00087114. He holds a B.E., M.S., and Ph.D., bringing more than seven decades of experience in the medical and pharmaceutical fields. The disclosure highlights that Dr. Himanshu C. Patel, Ms. Anar H. Patel, and Mr. Dinesh B. Patel are related to each other.

Ms. Anar Patel was also re-appointed as a Director liable to retire by rotation. The Board reported no qualifications from the Statutory or Secretarial Auditors in their respective reports for the period.

Secretarial auditor appointment details

Shareholders appointed M/s. Kashyap R. Mehta & Partners as Secretarial Auditors for five consecutive years, from FY27 to FY31. The firm is based in Ahmedabad and provides integrated legal and advisory services in Corporate Laws, Capital Markets, and Corporate Governance.

The appointment was confirmed under Regulation 30 of Listing Regulations. The disclosure notes that Yash K. Mehta, Managing Partner, has more than 15 years of post-qualification experience and has headed the private practice since its founding in 2015. The firm offers full-spectrum corporate, secretarial, regulatory, and compliance services. There are no disclosed relationships between the auditors and the Directors or the Company.

Voting participation details

Remote e-voting facilities were provided to members from September 22, 2026, to September 24, 2026. During the AGM, additional e-voting was available for attendees who had not voted remotely. A total of 42 folios participated in the voting process, representing 88,69,232 votes out of the total outstanding shares.

The AGM commenced at 12:00 pm and concluded at 12:14 pm IST. Dr. Himanshu C. Patel chaired the session as directed by Chairman Dinesh Patel.

Denis Chem Lab Limited has issued the notice for its 45th Annual General Meeting (AGM), scheduled for September 25, 2026. The meeting will be conducted through Video Conferencing or Other Audio Visual Means (OAVM) in compliance with Ministry of Corporate Affairs (MCA) circulars. The board has recommended a final dividend of ₹2.50 per equity share of face value ₹10 each for the financial year ended March 31, 2026, an increase from ₹1.50 per share in the previous year.

Key Agenda Items

The AGM agenda includes ordinary business items such as the adoption of audited financial statements for FY26 and the re-appointment of Ms. Anar Patel as a director retiring by rotation. Special business items focus on governance and management continuity:

• Re-appointment of Managing Director: Shareholders are asked to pass a special resolution to re-appoint Dr. Himanshu Patel as Managing Director for a period of three years, from August 1, 2026, to July 31, 2029. Dr. Patel, who is currently aged 72, requires shareholder approval under Section 196 of the Companies Act, 2013, as he has attained the age of 70 years.
• Auditor Appointments: The board seeks ratification for the remuneration of M/s. Kiran J. Mehta & Co. as Cost Auditors for FY27 and proposes the appointment of M/s. Kashyap R. Mehta & Partners as Secretarial Auditors for five consecutive financial years from FY27 to FY31.

Financial Context

During FY26, the company reported revenue from operations of ₹18,172.04 lakh (approximately ₹181.72 crore), compared to ₹17,329.97 lakh in FY25. The net profit after tax stood at ₹840.93 lakh, up from ₹807.58 lakh in the prior year. The proposed dividend payout reflects this growth in profitability.

What the Numbers Show

The increase in the final dividend recommendation from ₹1.50 to ₹2.50 per share aligns with the company’s improved bottom line. With net profit rising by approximately 4% YoY while revenue grew by nearly 5%, the higher dividend indicates a willingness to return more capital to shareholders despite modest margin expansion. The total dividend amount is estimated at ₹346.91 lakh.

Voting and Logistics

Remote e-voting will be available from September 22, 2026, to September 24, 2026. The record date for determining dividend eligibility is September 18, 2026. Shareholders holding shares in physical form are urged to update their KYC details with the Registrar and Share Transfer Agent, MUFG Intime India Private Limited, to ensure seamless dividend processing.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE051G01012/10b4cbc6-61f4-481c-ab4a-e8e508bcf904.pdf